ABSTRACT
Introduction
Multiple Sclerosis (MS) symptoms vary greatly, but cognitive impairment may affect 40-70% of patients [1] [2] [3] . Cognitive processing speed (CPS) and episodic memory are most often involved, both having adverse impact on employment and quality of life [4] [5] [6] [7] [8] [9] .
Full characterization of cognitive ability in MS requires psychometric assessment of CPS and memory, using tests with established validity in MS samples. These tests may be brief, but typically require a one-on-one clinical evaluation with a psychologist or similarly trained professional. This approach is not practical for large-scale clinical, genetic or epidemiologic studies, which require an abundance of information to be collected on hundreds or thousands of participants. Thus, an easily administered, inexpensive and sensitive screening or monitoring assessment that could be given remotely would facilitate large sample studies of cognitive health in MS, and could also facilitate early identification of cognitive deficits. Currently, there is no formally validated test to assess MS cognitive function remotely. Further, feasibility studies involving remote testing of a large number of MS patients derived from a population representative sample have not been attempted.
We investigated cognitive function in a large sample of MS cases and controls using the Modified Telephone Interview for Cognitive Status (TICS-M), a telephone based assessment of cognitive function which was initially developed to screen for mild cognitive impairment and Alzheimer disease, and has been previously validated in a healthy elderly population 10, 11 . We examined factors influencing participation and tested for associations between the TICS-M score and: 1) sex, 2) measures of physical disability, and 3) established genetic and environmental susceptibility factors in MS cases. We also compared TICS-M scores between case and control groups, and TICS-M scores with a standardized measure of selfperceived cognitive function in case and control groups.
Materials and Methods

Study Population
MS cases and controls (n=1,700; 1,078 cases and 622 controls) were recruited from the Kaiser Permanente Medical Care Plan in Northern California Region (KPNC); an integrated health services delivery system with 3.3 million members in a 22-county service area in Northern California. KPNC membership is generally representative of the general population with respect to demographic characteristics; although, individuals from impoverished neighborhoods are underrepresented 12 . The study protocol was approved by the Institutional Review Boards of UC Berkeley and Kaiser Permanente Division of Research. All study participants provided written informed consent. MS cases met well-established disease criteria, as defined by McDonald et al 13 . MS cases were identified through electronic health records (EHR), as any KPNC member with at least one outpatient diagnosis of MS by a neurologist (multiple sclerosis, ICD9 code 340.xx); 95% had at least two MS diagnoses by a neurologist at study entry. Controls were randomly selected from current KPNC members without a diagnosis of MS or related condition (optic neuritis, transverse myelitis, or demyelination disease; ICD9 codes: 340, 341.0, 341. 
Exposure and Clinical Data Collection
Study participants completed a computer assisted telephone interview (CATI) administered by trained staff at study entry. Environmental exposure data included history of tobacco smoking (ever/never), history of infectious mononucleosis (IM; ever/never), parental and self-education level (7-level scale, doctoral degree=0 to less than high school=6), family history of MS (first degree relatives), current body mass index (BMI; kilograms/ meters 2 ), and history of vitamin D supplementation (ever/never) ( Table 1) . Current and past history of depression were also collected 15 . History of depression was categorized as ever if the participant answered yes to either of the following questions: "Have you ever had a period of at least two weeks when you were bothered most of the day, nearly every day, by feeling depressed, sad, down, or low?" or "Have you ever had a period of at least two weeks when you did not enjoy most things, even things you usually like to do?", and the participant reported having at least four symptoms of depression during that period. Participants who answered no to the proceeding questions but answered yes to one of the following questions: "Have you ever had a period of at least two weeks when you were bothered most of the day, nearly every day, by feeling irritable?" or "…by feeling anxious?", and who reported having at least five symptoms of depression during that period, were also defined as having a history of depression. Depressive periods had to last at least two weeks. Current depression was defined based on answering yes to the question: "Are you currently experiencing an episode of depression?" The current depressive episode was required to last at least two weeks. Age of onset of MS was determined as year of first self-reported clinical symptom, based on the following questions: "How old were you when you had your first clinical symptoms of MS?", "What were your first clinical symptoms of MS?" Information was collected from each MS case regarding the physical location of symptom onset for both first (and second) clinical attack. Year for disease onset was calculated using date of birth. Age of onset in the current study relied on the appearance of clinical symptoms only and was verified in the EHR when possible. Disease duration was calculated as time between age of symptom onset and interview date, rounded to nearest year. Disease course was categorized as relapsing- Abbreviations used: SD = standard deviation, TICS-M = modified Telephone Interview for Cognitive Status, IM = infectious mononucleosis, BMI = body mass index, MSSS = MS severity score, RRMS = relapsing remitting MS, SPMS = secondary progressive MS, DMT = disease modifying therapy. PCDS = perceived cognitive deficit score. Education (self and parental) was coded as 0=doctoral degree to 7=less than high school, indicating that less education is a risk factor. Student's T-test was used to compare continuous variables between cases and controls; chisquare statistic compared categorical variables. 16 , which was developed for MS to provide a self-reported measure of cognitive status, assessing attention, retrospective memory, prospective memory, and planning and organization. All participants completed the 5-item PDQ, and were asked to indicate how frequently they experienced each cognitive difficulty in each area, based on a 5-point scale ranging from 0 (never) to 4 (almost always). Total PDQ scores range from 0 to 20; higher scores represent greater perceived impairment.
Disease severity was measured using the Multiple Sclerosis Severity Score (MSSS) 17 , and was based on selfreported current ambulatory status and disease duration. Self-report of neurological impairment in MS has been previously validated 18 . The MSSS for each case in the current study was assigned using Global MSSS reference data derived from a large independent cohort of 9,892 patients with EDSS and disease duration ranging from 1 to >30 years 17 . The MSSS can range from 0-10 and was analyzed as a continuous variable, and as two dichotomous variables 19 : a binary MSSS variable was based on the median MSSS value (MSSS ≤5 vs. >5) with a smaller score indicating more 'mild' disease. The second dichotomous variable was based on extreme ends of the MSSS distribution, defined as MSSS <2.5 ('mild') vs. ≥7.5 ('severe') ( Table 1) .
Cognitive Score (TICS-M)
The TICS-M is a cognitive function test developed as a screening assessment for mild cognitive impairment/ dementia that can be administered in person or by telephone 10, 11, 20 . As part of the CATI, each participant was asked 14 questions to assess orientation; registration and free recall; attention and calculation; comprehension; semantic recent memory; language and repetition; and delayed recall. These areas were also considered as TICS-M subscores for analysis. The high item difficulty of the memory task gives TICS-M more discriminatory power in terms of cognitive performance of the general population compared to the mini-mental status exam (MMSE) 11 . The TICS-M is scored as the unweighted sum of correct answers with a maximum of 37 possible points. Each participant TICS-M score was corrected for self-reported education level 21 . A total of 11.5% of KPNC MS Research Program study participants (138 cases and 59 controls of 1,700 individuals) did not wish to complete the TICS-M assessment. These individuals were considered nonparticipants for remote cognitive assessment, and were compared with remote cognitive assessment participants for clinical and demographic similarities and differences.
Genotyping
Biospecimens were collected as described 14 . DNA samples were genotyped using Illumina's Human 660K BeadChip; genotypes were further imputed using the 1000 Genome Reference, IMPUTE2 and standard procedures 22 . HLA-DRB1*15:01 genotype status was assigned as described 23 . Analyses were restricted to participants who clustered in a homogenous subset based on two dimensions of separation by classical multidimensional scaling (PLINK v1.07) 24 . A total of 29 individuals were removed. Our final dataset for analysis included 921 cases and 553 controls, for whom full clinical, genetic, exposure and TICS-M data were available.
Statistical Analyses
Student's T-test and the chi-square statistic were used to compare the distribution of variables between MS cases and controls (Table 1) and between participants and nonparticipants for remote cognitive assessment (TICS-M). Logistic regression models were used to estimate beta values (β) or odds ratio (OR), respectively, and 95% confidence intervals (95% CIs), for the association between the outcome of participating in remote cognitive assessment and the following predictors: case status, sex, PDQ score, history of smoking, age, measures of education and depression at study entry.
Unadjusted and adjusted linear and logistic regression models were used to estimate beta values (β) or odds ratio (OR), respectively, and 95% confidence intervals (95% CIs) in case-control models with MS case status as the predictor, and case-only models. The outcome was the TICS-M score and six subscores. Additional covariates were: year of birth, sex, history of smoking and IM, self-and parental-education level, current and history of depression, immediate family history of MS, current BMI, vitamin D intake, and HLA-DRB1*15:01 status. Case-only models used the following predictors: MSSS and HLA-DRB1*15:01 carrier status. Caseonly models also included age of onset, disease course, and DMT use as covariates. All variables were included initially; however, only variables that significantly affected outcome (predictor), after backward stepwise elimination (α-level=0.05), were retained in final adjusted models. STATA v13.1 (StataCorp, TX) was used for all analyses. Regression analyses were then repeated using stepwise elimination with both forward and backward selection for comparison; final models were based on Akaike information criterion 25 , and performed using the R package MASS 26 . A power analysis was carried out for both the casecontrol and case-only analyses 27, 28 . The current study was well powered (Supplementary Table 1) .
Results
MS cases were more likely to have smoked, have a history of IM, report a family history of MS, have current depression, have a higher self-perceived cognitive deficits (PDQ) score, and to have an increased carrier frequency of HLA-DRB1*15:01 compared to controls, as expected ( Table 1 ). The TICS-M scores ranged from 8-36, and were normally distributed in cases and controls (Supplementary Figure 1) .
We compared KPNC study participants who completed the TICS-M assessment with those who did not, for association with case status, sex, PDQ score, history of smoking, age, education and depression at study entry. We examined both the individuals in the current study with complete genetic, clinical and environmental exposure data (n=1,700; our original study sample) and our larger population sample that included an additional 964 individuals without complete genetic data at the time of study (total n=2,664). Cases, female participants and individuals with no (or who had parents with no) college degree were more likely to refuse the TICS-M than controls, male participants, and individuals with (and/or had parents with) a college degree (all p<0.001, Table 2 ). Age at study entry did not influence participant TICS-M refusal. Further, significant differences were not observed for PDQ scores between cases who completed the TICS-M and cases who did not, and similar results were shown for controls, even after adjustment for age and sex (p > 0.20, data not shown). Finally, among MS cases, the PDQ score was also significantly associated with TICS-M score (β =-0.14, p=8.9 x 10 -7
), controlling for sex, current depression, MSSS, parental college status, and age at onset. Among controls, the PDQ score was also significantly with TICS-M (β =-0.16, p=6.6 x 10 -12
), controlling for sex, current depression, age and parental college status. In both of these models, worse perceived cognitive deficits were associated with worse performance on the TICS-M.
In the case-only analysis, year of birth, history of smoking, parental-education, current depression, disease course, and MSSS were significantly associated with the TICS-M score when each variable was considered in univariate analysis (p<0.05, data not shown). The strongest association was observed for sex (β=-1.46, p=<0.001, data not shown). On average, male MS cases had lower cognitive scores compared to female cases. Similarly, cases who were older, who were smokers, whose parents had a lower level of education, who were currently depressed, or who had a more progressive/unknown disease course at onset demonstrated lower cognitive scores. MS cases with more severe disease, as measured by MSSS, had a lower TICS-M score, even after controlling for these covariates (Table  3) . Notably, individuals with very severe MS (MSSS ≥7.5) had a lower TICS-M score compared to those with a benign
Participants
TICS-M Test Participant
Yes (%) Variables in the primary model were coded as: sex (0=female), age of onset (years), parentaleducation (0=doctoral degree to 7=less than high school), and disease course (0=RRMS and SPMS, 1=PPMS, PRMS or unknown). These results suggest that, on average, men with MS have a lower cognitive score assessed with the TICS-M than women with MS; individuals with a later age of onset of MS had a higher cognitive score; individuals with MS who had parents with less education had a lower cognitive score than individuals with MS who had parents with more education; Individuals with PPMS, PRMS or unknown disease course had a lower cognitive score than those with RRMS or SPMS. (Table 3) . Consistent associations were also observed between an older age of onset, lower parentaleducation, disease course and a lower TICS-M score. No evidence for association between HLA-DRB1*15:01 and cognitive status was observed in cases (data not shown).
TICS-M Test
The TICS-M score also differed significantly between MS cases and controls (Table 1) ; this association persisted in multivariable regression models (Table 4A and 4B). On average, the TICS-M score was lower in cases than controls (mean difference of -0.60, p=0.001) ( Table 1) ; results were consistent with models adjusted for current depression, history of depression, year of birth, sex, smoking and parental-education (β=-0.53, p=0.007) (Table 4A) . Further, when cases with disease duration less than five years were compared to controls, the association persisted (data not shown). Significant differences were detected between cases and controls when the TICS-M was measured as orientation, registration, and delayed-recall (Table 4B) , though power for subscore analysis was limited. When stepwise regression with both forward and background elimination was used, there were some occasional differences in which variables were included in the models, but the main findings remained the same.
Discussion
Cognitive impairment is common in MS and related to multiple facets of cerebral pathology. Traditional professionally administered psychometric tests are not practical or affordable in large epidemiologic studies. The goal of this study was to determine whether MS patients (and controls) would participate in remote studies involving cognitive assessment, and to determine which characteristics distinguished participants and nonparticipants. We identified factors that influenced study participation rates. We investigated the relationship between MS risk factors and TICS-M score in cases, and score differences between cases and controls. Our results indicate for the first time, that a remotely administered cognitive assessment is quite feasible for conducting large epidemiologic studies in MS, and lay the much needed foundation for future work in this area that utilizes remote MS-validated cognitive testing.
The TICS-M is a telephone administered test previously validated as a screen for aging related diseases such as mild cognitive impairment and Alzheimer Disease 11 . Scores derived in the current study were significantly correlated with self-perceived cognitive deficits collected through selfreport for each participant using the PDQ at the same time the objective TICS-M was performed, controlling for sex, current depression and parental education. On average, the TICS-M score was significantly lower in MS cases when compared to controls, even after accounting for age, sex, education, depression and smoking status 15 . Importantly, findings persisted when cases were restricted to those with disease duration of less than five years, suggesting that the TICS-M might be sensitive for patients early in the disease course with cognitive impairment. The TICS-M score was also significantly associated with the PDQ score, controlling for sex, current depression and parental education.
The TICS-M score was inversely associated with physical disability (MSSS) in MS cases. (Pearson's correlation coefficient r = -0.158). As physical disability increased, so did evidence for cognitive impairment (Table  3) . Several clinical variables were also associated with the TICS-M score in cases, including sex, age of onset, parentaleducation, smoking and disease course; results are in strong agreement with previous studies using in-person, This primary model uses case status as a predictor for the TICS-M score. On average, MS cases had a -0.53 lower score than controls after adjustment. The difference from the primary model persisted when restricting to MS cases with less than five years of disease duration as compared to controls (data not shown). Backward elimination was used to retain variables in the final models, see Methods for details. Variables in the primary model were coded as: case-control status (0=control), current depression (0=not depressed), history of depression (0=never depressed), year of birth (years), sex (0=female), smoking (0=never smoked), parental-education (0=doctoral degree to 7=less than high school). Statistically significant subscores were orientation, registration, and delayed-recall. Models were adjusted for: current and history of depression, year of birth, sex, smoking, self-and parental-education. Self-education was added in the sub-score models because there was no correction made for the sub-scores. Self-education was coded as: 0=doctoral degree to 7=less than high school. 31 . Several additional and independent MHC risk variants also contribute to MS susceptibility 30 . Additional work is needed to exclude a relationship between MHC genes and cognitive dysfunction in MS. Recent genomewide association studies (GWAS) and targeted candidate gene approaches have identified 110 non-MHC risk variants for MS 23, 32 . Environmental factors also confer risk of developing MS, including childhood/adolescent obesity, low levels of vitamin D, and exposure to cigarette smoke 33 .
The genetic and environmental influences on MS associated cognitive impairment are largely unknown.
This study demonstrates that almost all MS cases and controls who were invited to undergo telephoneadministered cognitive testing agreed to participate. Our analyses suggest that cases, female participants and individuals (or individuals with parents) with no college degree were more likely to refuse assessment with the TICS-M. Future studies can implement strategies to help encourage females with MS to participate. Importantly, among cases who completed the TICS-M assessment versus those that did not, no significant differences were observed for PDQ scores, suggesting self-reported cognitive status is not a strong predictor of whether a MS case might participate in remote cognitive assessment. Similar results were shown for controls. Though the difference in TICS-M score between cases and controls was small, this study provides evidence that cases and controls do perform differently and that, more importantly, MS cases are indeed willing to participate in remote cognitive assessment. While the TICS-M has not yet been validated for MS, it is a validated tool for cognitive assessment and is similar to the California Verbal Learning Test-II 34 which has been previously validated for MS 35 .
The current study had several strengths. We investigated the largest sample of MS cases and controls, to date, for a measure of cognitive impairment, and using remote assessment. Further, both cases and controls were drawn from the same population (KPNC) and are well characterized. Prevalent cases were studied, including those with very recent symptom onset. Distribution of disease course, as indicated by clinical histories, shows our case sample was representative of other established cohorts; for example, our sample was higher in proportion for females, ~80% of cases were relapsing-remitting at onset 19 , and expected associations with established genetic and environmental risk factors were observed. Importantly, we controlled for potential confounders such as DMT use. Further, two variables captured history of depression and current depression at time of TICS-M administration; both can affect cognitive performance 15 and were included in models. Additionally, accounting also for other covariates such as sex and parental-education that were associated with the TICS-M score, indicates the observed difference between cases and controls is likely due to cognitive impairment, as measured by TICS-M. Self-education, which differed at baseline between cases and controls (Table  1) , can impact the TICS-M score. Scores were therefore corrected prior to analysis 21 . Results based on the TICS-M score were consistent with results for self-perceived cognitive deficits score measured with the PDQ
.
While we are encouraged by these findings, this work falls short of establishing the reliability and validity of the TICS-M in MS. The psychometric standards necessary for validation are well known 36 , and this study did not examine test-retest reliability, sensitivity compared to conventional testing, or convergent validity. We acknowledge that the TICS-M emphasizes verbal memory and language, domains that are more relevant for mild cognitive impairment and Alzheimer Disease, and, are a better match for a telephonebased assessment. Furthermore, assessment of visualrelated cognitive deficits cannot be assessed with the TICS-M and processing speed is not measured. However, the TICS-M has been utilized successfully in randomized controlled trials and large-scale population studies 37, 38 and we are presently pursuing similar approaches for the MS community using the Brief International Cognitive Assessment for MS 36 as a base for this assessment. Pilot work 39 suggests that a telemedicine approach to the symbol digit modalities test is feasible, although the optimal format and test form is yet to be determined. Other pilot work suggests that remotely-delivered cognitive remediation is feasible for individuals with MS 40 . Further, our study participants did not refuse testing for depression which must be measured at the time of any cognitive assessment in MS. This finding also supports the feasibility of remote cognitive testing.
Our study was restricted to white non-Hispanic KPNC members; thus, potentially limiting generalizability to non-white populations. The case-only analysis of cognitive impairment described here was partly cross-sectional, as the MSSS and the TICS-M score were both assessed at study entry; therefore, it is not possible to establish temporality between disease severity and cognitive status. However, this was not true for other variables, such as sex and genotype. Several other risk factors that can affect cognitive impairment, such as use of alcohol, disease comorbidities, and treatments for symptom management were not studied. Because socioeconomic status (SES) has been shown to be associated with MS 14 , differences in TICS-M participation based on this variable has the potential to induce a selection bias in the study. Lower SES (using parental-education as a proxy) was associated with refusal to complete the TICS-M. Therefore, association between the TICS-M score and case status is expected to be biased towards the null, meaning the true association may be stronger than what was observed. Controlling for parentaleducation in our case-control models was necessary, due to the association between this variable and cognitive impairment. Because the TICS-M score is corrected for self-education prior to analysis, the potential for selection bias or confounding was addressed. Given that females were more likely to refuse the TICS-M, the true association between sex and the TICS-M score could be biased towards the null, since males were more likely to experience greater cognitive impairment.
In summary, our results suggest a remotely administered cognitive assessment is feasible for future large studies. Non-participants in telephone-administered cognitive assessment were more likely to be an MS case, female and have lower educational status. Male sex, history of smoking and a more progressive disease course were associated with lower TICS-M scores in cases; these findings are in strong agreement with previous reports based on inperson, MS-validated neuropsychological tests. Early identification of cognitive dysfunction through screening and full characterization of clinical, environmental, and genetic predictors of poor cognitive health outcomes will have benefits in clinical settings through intervention 2 and ultimately prevention; much larger studies are needed that utilize MS-validated cognitive assessments.
